SIGA

SIGA Technologies Inc.

SIGA | $8.65 -1.26% -1.27% 430K

(0.0% 1d) (4.1% 1m) (57.7% 1y) (0.0% 2d) (-1.1% 3d) (3.8% 7d) (-50.49% volume)
Earnings Calendar:
Market Cap: $ 614,942,478
http://www.siga.com
Sec Filling | Patents | 41 employees

(US) SIGA Technologies, Inc. engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The company develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.

smallpox pathogens antiviral brands monkeypox dengue dividends!

Drugs

TPOXX (tecovirimat monohydrate)

add to watch list Paper trade email alert is off

Press-releases

SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®
Published: 2024-04-01 (Crawled : 20:00) - globenewswire.com
SIGA | $8.65 -1.26% -1.27% 430K

Health Technology

| -1.48% | O: 0.46% H: 13.25% C: 9.29%
tpoxx international agreement growth

SIGA Names Larry Miller General Counsel
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
SIGA | $8.65 -1.26% -1.27% 430K

Health Technology

| -1.14% | O: -7.42% H: 5.73% C: 2.96%
PHAT | $9.12 0.66% 0.66% 440K

Health Technology

| -17.24% | O: 2.09% H: 0.98% C: -7.11%

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023
Published: 2024-03-12 (Crawled : 20:00) - globenewswire.com
SIGA | $8.65 -1.26% -1.27% 430K

Health Technology

| 62.78% | O: 12.59% H: 10.56% C: 7.68%
financial results

SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-05 (Crawled : 12:30) - globenewswire.com
SIGA | $8.65 -1.26% -1.27% 430K

Health Technology

| 70.14% | O: 0.0% H: 0.59% C: -2.55%
business year update financial results

SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer
Published: 2024-01-22 (Crawled : 12:30) - globenewswire.com
SIGA | $8.65 -1.26% -1.27% 430K

Health Technology

| 68.81% | O: -1.56% H: 2.08% C: 1.19%

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023
Published: 2023-11-07 (Crawled : 21:00) - globenewswire.com
SIGA | $8.65 -1.26% -1.27% 430K

Health Technology

| 67.83% | O: -11.24% H: 9.83% C: 5.24%
financial results

SIGA Technologies to Host Business Update Call on November 7th, 2023 Following Release of Third Quarter 2023 Financial Results
Published: 2023-10-26 (Crawled : 12:00) - globenewswire.com
SIGA | $8.65 -1.26% -1.27% 430K

Health Technology

| 67.5% | O: -0.58% H: 1.95% C: 0.58%
business update financial results

SIGA Announces Creation of Joint Procurement Mechanism by European Commission with Anticipated Initial Orders of Approximately $18 Million for Oral TPOXX® (Tecovirimat) by Participating Countries
Published: 2023-10-23 (Crawled : 12:00) - globenewswire.com
SIGA | $8.65 -1.26% -1.27% 430K

Health Technology

| 67.83% | O: 0.19% H: 2.51% C: 1.55%
tpoxx

SIGA Technologies Names Dr. Jay K. Varma as EVP and Chief Medical Officer
Published: 2023-09-06 (Crawled : 12:00) - globenewswire.com
SIGA | $8.65 -1.26% -1.27% 430K

Health Technology

| 92.87% | O: 0.22% H: 0.22% C: -2.22%
medical

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2023
Published: 2023-08-08 (Crawled : 20:00) - globenewswire.com
SIGA | $8.65 -1.26% -1.27% 430K

Health Technology